Organigram reported $80.1M Q4 2025 net revenue and $259.2M for fiscal 2025, driven by recreational and international cannabis sales despite ongoing net losses.
Trending
- FDA Is 9 Months Late In Publishing Legally Mandated Hemp Guidance, And Congressional Researchers Are Calling The Agency Out
- DEA Boosts Psychedelic Production Quotas For 2027 While Previewing Separate Marijuana Proposal Under Rescheduling
- Missouri Officials Warn Marijuana Businesses That Interstate Commerce Is Not Allowed, Even Under Federal Rescheduling
- Kentucky Medical Cannabis Program Surpasses 30,000 Patients
- Incoming Texas Lieutenant Governor Discusses Options For Cannabis Reform, Including Full Legalization Or Medical Expansion
- Missouri AG Suing Four Retailers for Illegal Cannabis Sales
- North Carolina Has A Chance To Finally Legalize Marijuana After Last Week’s Elections (Op-Ed)
- Cannabis Can Be The Issue That Unites A Divided Federal Government (Op-Ed)



